Niteen B. Gadgil

25+ year career; Last engagement : Managing Director of Solvay Pharma India Ltd., a listed pharma MNC of Solvay group, Belgium

Experience in

• General Management – Strategy & execution,
• Mergers & Acquisitions
• Finance, Tax
• Legal & Secretarial
• Supply Chain Management
• IT, ERP implementation
• Budgeting, Costing and Budgetary control

Worked in different industries,

• Pharma
• Steel
• Electrical / Industrial Engineering

Education:

• Chartered Accountant
• Company Secretary
• Cost Accountant
• CISA (non-practising) from ISACA, USA
• Dip. Business Finance (ICFAI)
• Cert. in Intellectual Property Rights from IIPS

Former Member of

• Board of Directors of Solvay Specialities India P. Ltd.
• Executive Committee of OPPI (Pharma Industry Association) and also,
• Taxation Committee of BCCI

Mr. Deepak Kanvinde

3+ decades of experience spread across Pharmaceuticals, Biotech, Medical Devices & Diagnostics sectors & knowledge of products, markets & technologies.

ex-President (Sales, Marketing & Business Development), Piramal Healthcare (PHL). He was instrumental in many licensing deals & in acquisitions by PHL during his tenure

Prior to PHL, held leadership positions with healthcare companies including ConvaTech (Medical devices unit of BMS), German Remedies, Johnson & Johnson etc.

Deepak is a Graduate in Science with post graduate qualification in Management from University of Mumbai.

Dr. Albrecht Laeufer, Corvay GmbH, Germany

Advisor to the biotech, pharma and chemical industries

Dr. Albrecht Läuferis accredited consultant to the Nbank and the KfW.

He has more than 30 years of international management experience in the pharmaceutical and chemical industry sector (Solvay, Rütgerswerke) in leading positions.

At Solvay Pharmaceuticals he was responsible for all countries of Asia, for Canada and Australia, Turkey, the Near East as well as South Africa as “Regional Director”. As CEO of Solvay Enzymes he took responsibility for the worldwide market with detergent enzymes as well as the whole enzyme marketing in Europe.

In 2002 he was co-founder of the Vakzine Projekt Management (VPM), which he established from 2003-2008 as executive manager. In 2002 he was also co-founder of Corvay GmbH. Since 2008 he is sole owner and CEO of Corvay.

Dr. Läufer studied Biochemistry in Tübingen, Germany and Chemistry in Basel, Swiss. He received his PhD from the University of Bruswick in physical chemistry.

http://corvay.de/